The Journal of Immunology, Vol 159, Issue 8 3995-4005, Copyright © 1997 by American Association of Immunologists

ARTICLES

Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway: L-cladinose is involved both in alterations of neutrophil functions and modulation of this transductional pathway

H Abdelghaffar, D Vazifeh and MT Labro
INSERM Unite 294, Centre Hospitalier Universitaire Xavier Bichat, Paris, France.

All erythromycin A derivatives, irrespective of the size of the lactone ring and the nature of the substituent, inhibit oxidant production by neutrophils and promote their degranulation. We demonstrate in this study that the L-cladinose at position 3 of the lactone ring is a key structure in the modulation of these two neutrophil functions, suggesting that this sugar (alone or combined with a lactone structure) interferes with cell target(s) involved in both oxidant production and exocytosis. Taking roxithromycin as an example of erythromycin A derivatives, we also found that these molecules interfered with the phospholipase D (PLD)-phosphatidate phosphohydrolase pathway in two ways. In nonstimulated neutrophils, roxithromycin and all L-cladinose- bearing molecules activated PLD, as reflected by 1-O-[3H]alkyl-2-acyl- phosphatidyl-ethanol production. In addition, these drugs induced an accumulation of 1-O-[3H]alkyl-2-acyl-phosphatidic acid (PA), but not 1- O-[3H]alkyl-2-acylglycerol. PA accumulation seems to be involved in the induction of exocytosis by macrolides, as the roxithromycin-induced release of granular enzymes was impaired strongly in the presence of ethanol. By contrast, in stimulated neutrophils, roxithromycin inhibited PLD activity and totally impaired 1-O-[3H]alkyl-2- acylglycerol production. The inhibition of diglyceride production by roxithromycin (not its descladinosyl derivative) could explain its inhibitory effect on oxidant production. The relevance of our data to the clinical situation, particularly the anti-inflammatory activity of these drugs, requires further investigation.

This article has been cited by other articles:

				Y. Liu and B. L. Fanburg Phospholipase D signaling in serotonin-induced mitogenesis of pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L471 - L478. [Abstract] [Full Text] [PDF]

				A. C. Williams, H. F. Galley, A. M. Watt, and N. R. Webster Differential effects of three antibiotics on T helper cell cytokine expression J. Antimicrob. Chemother., September 1, 2005; 56(3): 502 - 506. [Abstract] [Full Text] [PDF]

				H. Abdelghaffar, C. Babin-Chevaye, and M.-T. Labro The Macrolide Roxithromycin Impairs NADPH Oxidase Activation and Alters Translocation of Its Cytosolic Components to the Neutrophil Membrane In Vitro Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2986 - 2989. [Abstract] [Full Text] [PDF]

				W. C. Tsai, M. L. Rodriguez, K. S. Young, J. C. Deng, V. J. Thannickal, K. Tateda, M. B. Hershenson, and T. J. Standiford Azithromycin Blocks Neutrophil Recruitment in Pseudomonas Endobronchial Infection Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1331 - 1339. [Abstract] [Full Text] [PDF]

				M. J. Schultz Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis J. Antimicrob. Chemother., July 1, 2004; 54(1): 21 - 28. [Abstract] [Full Text] [PDF]

				M. T. Labro, H. Abdelghaffar, and C. Babin-Chevaye Interaction of the New Ketolide ABT-773 (Cethromycin) with Human Polymorphonuclear Neutrophils and the Phagocytic Cell Line PLB-985 In Vitro Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1096 - 1104. [Abstract] [Full Text] [PDF]

				D. Vazifeh, H. Abdelghaffar, and M. T. Labro Effect of Telithromycin (HMR 3647) on Polymorphonuclear Neutrophil Killing of Staphylococcus aureus in Comparison with Roxithromycin Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1364 - 1374. [Abstract] [Full Text] [PDF]

				M. Gorrini, A. Lupi, S. Viglio, F. Pamparana, G. Cetta, P. Iadarola, J. C. Powers, and M. Luisetti Inhibition of Human Neutrophil Elastase by Erythromycin and Flurythromycin, Two Macrolide Antibiotics Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 492 - 499. [Abstract] [Full Text] [PDF]

				M.-T. Labro Interference of Antibacterial Agents with Phagocyte Functions: Immunomodulation or ""Immuno-Fairy Tales""? Clin. Microbiol. Rev., October 1, 2000; 13(4): 615 - 650. [Abstract] [Full Text] [PDF]

				M. J. Schultz, P. Speelman, C. E. Hack, W. A. Buurman, S. J. H. van Deventer, and T. van der Poll Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae J. Antimicrob. Chemother., August 1, 2000; 46(2): 235 - 240. [Abstract] [Full Text] [PDF]

				D. Vazifeh, A. Bryskier, and M. T. Labro Effect of Proinflammatory Cytokines on the Interplay between Roxithromycin, HMR 3647, or HMR 3004 and Human Polymorphonuclear Neutrophils Antimicrob. Agents Chemother., March 1, 2000; 44(3): 511 - 521. [Abstract] [Full Text]

				D. Vazifeh, A. Preira, A. Bryskier, and M. T. Labro Interactions between HMR 3647, a New Ketolide, and Human Polymorphonuclear Neutrophils Antimicrob. Agents Chemother., August 1, 1998; 42(8): 1944 - 1951. [Abstract] [Full Text]